• Publications
  • Influence
Selenium, zinc and copper plasma levels in intrahepatic cholestasis of pregnancy, in normal pregnancies and in healthy individuals, in Chile.
BACKGROUND/AIMS Low blood Se levels have been previously shown in normal pregnancies (third trimester) and significantly lower levels in patients with intrahepatic cholestasis of pregnancy (ICP), inExpand
  • 131
  • 6
Etiology of hepatocellular carcinoma in Latin America: a prospective, multicenter, international study.
BACKGROUND/AIMS No prospective study has been published investigating etiology of HCC in Latin America. The primary aim of this prospective study was to analyze the etiology of liver disease inExpand
  • 47
  • 5
  • PDF
Acute and fulminant hepatitis induced by flutamide: case series report and review of the literature.
Flutamide is a non-steroidal anti-androgenic drug, commonly used in the treatment of advanced prostate cancer, acne and hirsutism. This drug may induce various degrees of liver injury, includingExpand
  • 44
  • 3
Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy.
  • R. Zapata, L. Sandoval, +6 authors Juan Jorge Silva
  • Medicine
  • Liver international : official journal of the…
  • 1 June 2005
Abstract: Objective: To assess the efficacy of ursodeoxycholic acid (UDCA) in patients with intrahepatic cholestasis of pregnancy (ICP) and in the outcome of pregnancy.
  • 117
  • 2
Management of nonalcoholic fatty liver disease: an evidence-based clinical practice review.
AIM To build a consensus among Chilean specialists on the appropriate management of patients with nonalcoholic fatty liver disease (NAFLD) in clinical practice. METHODS NAFLD has now reachedExpand
  • 47
  • 2
  • PDF
Liver transplantation for hepatocellular carcinoma: evaluation of the alpha‐fetoprotein model in a multicenter cohort from Latin America
The French alpha‐fetoprotein (AFP) model has recently shown superior results compared to Milan criteria (MC) for prediction of hepatocellular carcinoma (HCC) recurrence after liver transplantationExpand
  • 47
  • 1
  • PDF
Latin American Association for the Study of the Liver (LAASL) clinical practice guidelines: management of hepatocellular carcinoma.
Hepatocellular carcinoma (HCC) is the fifth most common cancer in the world and the third most common cause of cancer death, and accounts for 5.6% of all cancers. Nearly 82% of the approximatelyExpand
  • 34
  • 1
  • PDF
Profile of idiosyncratic drug induced liver injury in Latin America: an analysis of published reports.
INTRODUCTION Drug-induced liver injury (DILI) remains a major problem for drug development and represents a challenging diagnosis for clinicians. The absence of specific biomarkers for diagnosingExpand
  • 23
  • 1
  • PDF
Post‐transplant lymphoproliferative disorder in adult liver transplant recipients: a South American multicenter experience
Post‐transplant lymphoproliferative disorder (PTLD) is a major and potentially life‐threatening complication after solid‐organ transplantation. The aim of this study was to describe the diseaseExpand
  • 9
  • 1